 Animal models arterial thrombolysis prevention reocclusion Erythrocyte-rich platelet-rich thrombus Experimental animal models erythrocyte-rich ER platelet-rich PR arterial thrombosis dogs rabbits evaluation effect antithrombin antiplatelet agents thrombolysis recombinant tissue-type plasminogen activators rt-PA canine models whole blood clot left anterior coronary artery ER thrombus everted inside-out segment graft circumflex coronary artery PR material PR thrombus rabbit models femoral arterial whole blood clot ER thrombus femoral arterial eversion graft PR thrombus whole blood clot models sensitive rt-PA reocclusion concomitant use heparin and/or aspirin Clot lysis reocclusion administration fragments monoclonal antibody platelet glycoprotein IIb/IIIa receptor Argatroban synthetic thrombin inhibitor kistrin glycoprotein IIb/IIIa-blocking polypeptide Malayan pit viper venom PR thrombus models resistant rt-PA resistance concomitant use platelet IIb/IIIa-blocking antibody selective platelet glycoprotein IIb/IIIa inhibitors effective heparin arterial thrombolysis rt-PA reocclusion clot lysis resistance PR thrombus dispersion rt-PA experimental animal models useful development improved thrombolytic strategies plasminogen activators conjunction antiplatelet anticoagulant agents